Attention Joslin Patients:

Joslin Diabetes Center's COVID-19 pandemic hybrid care model allows patients to tailor their care with remote and in-person services, including telehealth visits. Please visit our main COVID-19 page for all this information in both English and Spanish. Please access COVID Pass the day of any on-site appointment to answer screening questions to receive a pass. 
 

Currently, Joslin does not have a supply of COVID-19 vaccine.  Vaccine availability and distribution are controlled by federal and state authorities. If the vaccine becomes available to us, Joslin will adhere to the state's plan for prioritized distribution. Please monitor the COVID-19 page on our website for updates.

Alert Close

Dr. Kyoungmin Park focuses on investigating the molecular mechanisms underlying insulin’s action on the vascular wall and developing new therapeutic drugs for macrovascular complications, atherosclerosis in Type 2 diabetes. Additionally, working to determine the role of autoimmunity or autoimmune disease in the severity and development of atherosclerosis in Type 1 diabetes, diabetes-related disease, including cardiovascular disease.

Contact Information

Office Phone

(617) 309-2660

Kyoungmin.park [at] joslin.harvard.edu

News Related to Kyoungmin Park

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

Insulin may drive the clogging of stents that often follows coronary angioplasties in people with diabetes. BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart...
Read more on Research may show way to minimize complications after heart treatment

Joslin researchers uncover protective factor in diabetic eye disease

Increased levels of RBP3 both protect against and treats diabetic retinopathy BOSTON – (July 3, 2019) – Researchers at Joslin Diabetes Center have shown that a protein found in the eye can protect...
Read more on Joslin researchers uncover protective factor in diabetic eye disease